Evidence map›Paper›PMID 38816422›Full record

ArticleScientific reports2024

Machine learning models for predicting blood pressure phenotypes by combining multiple polygenic risk scores.

Yana Hrytsenko, Benjamin Shea, Michael Elgart, Nuzulul Kurniansyah, Genevieve Lyons, Alanna C Morrison, April P Carson, Bernhard Haring, Braxton D Mitchell, Bruce M Psaty and 28 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

38 authors.

Yana Hrytsenko *Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Benjamin Shea *CardioVascular Institute (CVI), Beth Israel Deaconess Medical Center, Boston, MA, USA.
Michael ElgartDepartment of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Nuzulul KurniansyahDepartment of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Genevieve LyonsDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Alanna C MorrisonDepartment of Epidemiology, School of Public Health, Human Genetics Center, The University of Texas Health Science Center at Houston, Houston, TX, USA.
April P CarsonDepartment of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
Bernhard HaringDepartment of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Braxton D MitchellDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Bruce M PsatyDepartment of Medicine, University of Washington, Seattle, WA, USA.
Byron C JaegerDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
C Charles GuThe Center for Biostatistics and Data Science, Washington University, St. Louis, USA.
Charles KooperbergDivision of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Daniel LevyThe Population Sciences Branch of the National Heart, Lung and Blood Institute, Bethesda, MD, USA.
Donald Lloyd-JonesDepartment of Preventive Medicine, Northwestern University, Chicago, IL, USA.
Eunhee ChoiColumbia Hypertension Laboratory, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Jennifer A BrodyDepartment of Medicine, University of Washington, Seattle, WA, USA.
Jennifer A SmithDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Jerome I RotterDepartment of Pediatrics, The Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.
Matthew MollDepartment of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Myriam FornageDepartment of Epidemiology, School of Public Health, Human Genetics Center, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Noah SimonDepartment of Biostatistics, School of Public Health, University of Washington, Seattle, WA, USA.
Peter CastaldiDepartment of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Ramon CasanovaDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Ren-Hua ChungDivision of Biostatistics and Bioinformatics, Institute of Population Health Sciences, National Health Research Institutes, Taipei City, Taiwan.
Robert KaplanDepartment of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Ruth J F LoosThe Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Sharon L R KardiaDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Stephen S RichCenter for Public Health Genomics, University of Virginia School of Medicine, Charlottesville, VA, USA.
Susan RedlineDepartment of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Tanika KellyDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
Timothy O'ConnorDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Wei ZhaoDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Wonji KimChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, USA.
Xiuqing GuoDepartment of Pediatrics, The Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.
Yii-Der Ida ChenDepartment of Pediatrics, The Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.
Trans-Omics in Precision Medicine Consortium
Tamar SoferDepartment of Medicine, Brigham and Women's Hospital, Boston, MA, USA. tsofer@bidmc.harvard.edu.

Funding

University of Maryland Claude D. Pepper Older Americans Independence Center (UM-OAIC)P30AG028747 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI ALICE S. RYAN · 2006 to 2026
$28.9M
CHARGE Consortium: Omics Discovery for CVD and Aging PhenotypesR01HL105756 · NHLBI · UNIVERSITY OF WASHINGTON · PI Bruce M Psaty, NICHOLAS L SMITH · 2011 to 2026
$9.5M
Leveraging omics data to understand sleep health and its consequences among diverse Hispanics/LatinosR01HL161012 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Tamar Sofer · 2022 to 2026
$3.2M
Multi-omic Risk Prediction of Chronic Obstructive Pulmonary Disease in European- and African-Ancestry Populations_SupplementK08HL159318 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Matthew R Moll · 2022 to 2026
$918k
NHLBI NIH HHS K08 HL159318NHLBI NIH HHS R01 HL161012NHLBI NIH HHS R01HL161012NIA NIH HHS P30 AG028747
6 · The paper itself

Abstract

We construct non-linear machine learning (ML) prediction models for systolic and diastolic blood pressure (SBP, DBP) using demographic and clinical variables and polygenic risk scores (PRSs). We developed a two-model ensemble, consisting of a baseline model, where prediction is based on demographic and clinical variables only, and a genetic model, where we also include PRSs. We evaluate the use of a linear versus a non-linear model at both the baseline and the genetic model levels and assess the improvement in performance when incorporating multiple PRSs. We report the ensemble model's performance as percentage variance explained (PVE) on a held-out test dataset. A non-linear baseline model improved the PVEs from 28.1 to 30.1% (SBP) and 14.3% to 17.4% (DBP) compared with a linear baseline model. Including seven PRSs in the genetic model computed based on the largest available GWAS of SBP/DBP improved the genetic model PVE from 4.8 to 5.1% (SBP) and 4.7 to 5% (DBP) compared to using a single PRS. Adding additional 14 PRSs computed based on two independent GWASs further increased the genetic model PVE to 6.3% (SBP) and 5.7% (DBP). PVE differed across self-reported race/ethnicity groups, with primarily all non-White groups benefitting from the inclusion of additional PRSs. In summary, non-linear ML models improves BP prediction in models incorporating diverse populations.

Indexed as

Blood PressureGenome-Wide Association StudyMachine LearningMultifactorial InheritancePhenotypeFemaleGenetic Predisposition to DiseaseGenetic Risk ScoreHumansHypertensionMaleMiddle AgedModels, GeneticRisk Factors

Identifiers

PMID38816422
PMCPMC11139858

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.